Cash Flow Statement

Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Short-Term Debt issuances Short-Term Debt repayments

Growth Metrics

Bio Essence (BIOE) Cash from Discontinued Operations (2023 - 2024)

Bio Essence has reported Cash from Discontinued Operations over the past 2 years, most recently at 120825.0 for Q4 2024.

For Q4 2024, Cash from Discontinued Operations fell 79.01% year-over-year to 120825.0; the TTM value through Dec 2024 reached 15952.0, up 63.92%, while the annual FY2024 figure was 15952.0, 63.92% up from the prior year.
Cash from Discontinued Operations for Q4 2024 was 120825.0 at Bio Essence, up from 136777.0 in the prior quarter.
Over five years, Cash from Discontinued Operations peaked at 575766.0 in Q4 2023 and troughed at 267981.0 in Q3 2023.